PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6519389

Permanent physiological pacing.

P Rossi·G Rognoni·F Aina·E Occhetta
View original source ↗Export metadata ↓

Abstract

Ideal physiological form of pacing responds to body's needs for varying cardiac output indipendent of the requirement to synchronize with atrial activity. The atrial synchronous pacemakers are superior to the ventricular inhibited fixed rate pacing mode. Alternative methods of sensing physiological demands with single chamber ventricular pacing that produce a physiological rate response to exercise are described. System based on QT sensing and pacing system responsive to changes in respiratory rate have undergone successful clinical trials. Hemodynamics of rate responsive pacing are described. The highest cardiac performance during stress test in rate responsive pacing was achieved with the respiratory dependent pacemaker.

Explore related subjects

Cardiac OutputExercise TestHeart RateHemodynamicsHumansPacemaker, ArtificialRespirationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Rossi, G Rognoni, F Aina, E Occhetta. 1984. Permanent physiological pacing.. https://pubmed.ncbi.nlm.nih.gov/6519389/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Congestive heart failure due to hypertensive ventricular diastolic dysfunction.

Left ventricular (LV) diastolic dysfunction is the first discernible manifestation of heart disease in hypertensive patients. Arterial hypertension with LV hypertrophy leads to reduced preload followed by impaired cardiac output (systolic dysfunction stemming from primary diastolic dysfunction). Diastolic dysfunction leads more often than systolic dysfunction to hypertensive heart failure and is in many cases clearly distinguishable from heart failure with low ejection fraction (EF). Mortality due to heart failure from impaired inotropism is higher than mortality due to diastolic dysfunction, but morbidity is lower. Hypertensive cardiomyopathies can be divided into 4 ascending categories, according to the pathophysiologic and clinical impact of hypertension on the heart: Degree I: LV diastolic dysfunction with no associated LV hypertrophy Degree II: LV diastolic dysfunction with echocardiographic LV hypertrophy Degree IIA: Normal exercise capacity in terms of maximal oxygen consumption Degree IIB: Impaired exercise capacity in terms of maximal oxygen consumption Degree III: Congestive heart failure (severe dyspnea and radiographically determined pulmonary edema with normal (> or = 50%) EF Degree IIIA: LV mass/volume ratio > 1.8 with little or no myocardial ischemia Degree IIIB: LV mass/volume ratio < 1.8 with significant myocardial ischemia Degree IV: Profile of dilated cardiomyopathy; LV hypertrophy and impaired EF (< 50%).

Cardiac Output↗